8-K: U.S. Physical Therapy Reports Mixed Q1 Results but Raises Full Year Guidance

U.S. Physical Therapy reported a slight decrease in adjusted EBITDA for the first quarter of 2024, but increased full-year guidance due to strong performance in February and March and a favorable adjustment to Medicare rate reductions.

Summary

• U.S. Physical Therapy (USPH) announced its first quarter 2024 results, showing an adjusted EBITDA of $16.7 million, down from $18.5 million in the same period last year.
• The decrease in adjusted EBITDA was primarily due to Medicare rate reductions and adverse weather events in January, which reduced EBITDA by approximately $1.7 million and $1.3 million, respectively.
• Operating results were $7.7 million, consistent with the first quarter of 2023, but earnings per share decreased to $0.51 from $0.59 due to an increase in shares outstanding from a secondary offering.
• Net income attributable to USPH shareholders increased to $8.0 million from $7.4 million year-over-year.
• Total revenue from physical therapy operations increased by 4.1% to $134.4 million.
• The net rate per patient visit increased slightly to $103.37 from $103.12, despite a 3.5% Medicare rate reduction.
• Total patient visits increased by 3.3% to 1,268,002, while average daily visits per clinic decreased slightly to 29.5 from 29.8.
• Industrial injury prevention (IIP) services revenue increased by 9.8% to $21.3 million, with a 15.1% increase in gross profit.
• The company added 14 new clinics and closed six, bringing the total to 679 clinics as of March 31, 2024.
• USPH acquired a 50% equity interest in a nine-clinic practice for $16.4 million and Briotix Health acquired 100% of an IIP business for $24.0 million.
• Management raised full-year adjusted EBITDA guidance to a range of $82.5 million to $87.5 million.

Sentiment

Score: 7

Explanation: The sentiment is positive overall due to the raised full-year guidance and strong performance in February and March, despite some challenges in the first quarter. The company is showing resilience and strategic growth.

Positives

• Net income attributable to USPH shareholders increased to $8.0 million from $7.4 million year-over-year.
• Total revenue from physical therapy operations increased by 4.1% to $134.4 million.
• The net rate per patient visit increased slightly to $103.37 from $103.12, despite a 3.5% Medicare rate reduction.
• Total patient visits increased by 3.3% to 1,268,002.
• Industrial injury prevention (IIP) services revenue increased by 9.8% to $21.3 million, with a 15.1% increase in gross profit.
• The company added 14 new clinics, expanding its network.
• Management raised full-year adjusted EBITDA guidance to a range of $82.5 million to $87.5 million.
• The company saw strong volumes in February and March, recovering from a slow January.
• The company is seeing positive results from contract renegotiations and a focus on workers compensation.

Negatives

• Adjusted EBITDA decreased to $16.7 million from $18.5 million in the same period last year.
• The decrease in adjusted EBITDA was primarily due to Medicare rate reductions and adverse weather events in January.
• Operating results per share decreased to $0.51 from $0.59 due to an increase in shares outstanding.
• Average daily visits per clinic decreased slightly to 29.5 from 29.8.
• Gross profit from physical therapy operations decreased by 11.2% to $24.1 million.
• Salaries and related costs per visit increased to $61.42 from $59.14.
• Total operating costs per visit increased to $85.50 from $81.97.

Risks

• Changes in Medicare rules and reimbursement rates could negatively impact revenue.
• Future public health crises could disrupt operations and impact financial results.
• The company is subject to potential retroactive reductions in Medicare and Medicaid revenue.
• Changes in reimbursement rates from third-party payors could affect profitability.
• Compliance with privacy laws and regulations is crucial to avoid fines and penalties.
• Competitive conditions in the market could lead to clinic closures and losses.
• The company's debt and financial obligations could impact its ability to operate.
• The company depends on hiring and retaining qualified employees.
• Cybersecurity breaches could lead to legal action and reputational harm.
• The company's business is subject to weather and seasonal factors.

Future Outlook

Management increased full-year adjusted EBITDA guidance to a range of $82.5 million to $87.5 million, reflecting strong performance in February and March and a favorable adjustment to Medicare rate reductions. The guidance includes expected contributions from acquisitions that have closed or are expected to close in or shortly after the first half of 2024.

Management Comments

• Chris Reading, Chief Executive Officer, stated that visits have rebounded nicely after a slow January and the company is ahead of plan for the year.
• Chris Reading also mentioned that demand remains strong for their services and they are excited about new additions to their PT and IIP family of companies.
• Chris Reading noted that contract renegotiations and a focus on workers compensation are yielding positive results.
• Carey Hendrickson, Chief Financial Officer, added that revenue and EBITDA in the first quarter were higher than internal expectations due to strong volumes and continued progress in net rate.
• Carey Hendrickson also stated that the company has confidence to raise the full year EBITDA expectations by more than the approximate $2 million positive EBITDA impact of the previously reported Medicare rate adjustment.

Industry Context

The report indicates that USPH is navigating challenges in the healthcare sector, such as Medicare rate reductions, while also capitalizing on growth opportunities through acquisitions and strategic contract negotiations. The company's focus on expanding its IIP services aligns with a broader trend of employers prioritizing workplace safety and injury prevention. The increase in patient visits and revenue suggests a continued demand for physical therapy services, which is consistent with the aging population and increased awareness of the benefits of physical rehabilitation.

Comparison to Industry Standards

• U.S. Physical Therapy's performance can be compared to other publicly traded outpatient physical therapy providers such as Select Medical (SEM) and ATI Physical Therapy (ATIP).
• While USPH reported a slight decrease in adjusted EBITDA, it is important to compare this to the performance of its peers, some of whom may have faced similar challenges with Medicare rate reductions and weather impacts.
• The increase in net rate per patient visit for USPH, despite Medicare cuts, suggests effective contract negotiations, which is a key performance indicator in the industry.
• The company's acquisition strategy is also a common growth tactic in the industry, and the success of these acquisitions will be a key factor in future performance.
• USPH's focus on IIP services is a differentiator, as not all physical therapy providers have a significant presence in this area. The 15.1% increase in gross profit in this segment is a positive sign.
• The company's average daily visits per clinic of 29.5 is a key metric to compare against industry benchmarks, and the slight decrease may be a point of concern if it continues in future quarters.
• The company's cash position of $132.3 million is strong compared to some of its peers, which provides flexibility for future acquisitions and investments.

Stakeholder Impact

• Shareholders will benefit from the increased full-year guidance and the quarterly dividend of $0.44 per share.
• Employees may see opportunities for growth with the addition of new clinics and the expansion of IIP services.
• Customers will continue to receive physical therapy and injury prevention services.
• Suppliers will continue to provide necessary goods and services to the company.
• Creditors will be impacted by the company's debt and financial obligations.

Next Steps

• The company will continue to focus on growing its most profitable markets.
• The company will deploy capital for additional acquisitions.
• The company will continue its work on pricing.
• The company will continue to serve those entrusted to their care.
• Management will host a conference call on May 8, 2024, to discuss the results.

Key Dates

Keywords

physical therapy, outpatient clinics, industrial injury prevention, EBITDA, revenue, Medicare, acquisitions, clinic expansion, patient visits, reimbursement rates